Immature and Maturation-resistant Human Dendritic Cells Generated from Bone Marrow Require Two Stimulations to Induce T Cell Anergy in Vitro

Overview

Journal PLoS One

Specialties General Medicine
Science

Date 2009 Aug 15

PMID 19680551

Citations 14

Authors

Thomas G Berger

Hendrik Schulze-Koops

Michaela Schafer

Ester Muller

Manfred B Lutz

Affiliations

Soon will be listed here.

Abstract

Immature dendritic cells (DC) represent potential clinical tools for tolerogenic cellular immunotherapy in both transplantation and autoimmunity. A major drawback in vivo is their potential to mature during infections or inflammation, which would convert their tolerogenicity into immunogenicity. The generation of immature DC from human bone marrow (BM) by low doses of GM-CSF (lowGM) in the absence of IL-4 under GMP conditions create DC resistant to maturation, detected by surface marker expression and primary stimulation by allogeneic T cells. This resistence could not be observed for BM-derived DC generated with high doses of GM-CSF plus IL-4 (highGM/4), although both DC types induced primary allogeneic T cell anergy in vitro. The estabishment of the anergic state requires two subsequent stimulations by immature DC. Anergy induction was more profound with lowGM-DC due to their maturation resistance. Together, we show the generation of immature, maturation-resistant lowGM-DC for potential clinical use in transplant rejection and propose a two-step-model of T cell anergy induction by immature DC.

Citing Articles

NT-3 Combined with TGF-β Signaling Pathway Enhance the Repair of Spinal Cord Injury by Inhibiting Glial Scar Formation and Promoting Axonal Regeneration.

Chen T, He X, Wang J, Du D, Xu Y Mol Biotechnol. 2023; 66(6):1484-1495.

PMID: 37318740 PMC: 11101526. DOI: 10.1007/s12033-023-00781-4.

Guidelines for mouse and human DC generation.

Lutz M, Ali S, Audiger C, Autenrieth S, Berod L, Bigley V Eur J Immunol. 2022; 53(11):e2249816.

PMID: 36303448 PMC: 10704271. DOI: 10.1002/eji.202249816.

Activated dendritic cells modulate proliferation and differentiation of human myoblasts.

Ladislau L, Portilho D, Courau T, Solares-Perez A, Negroni E, Laine J Cell Death Dis. 2018; 9(5):551.

PMID: 29748534 PMC: 5945640. DOI: 10.1038/s41419-018-0426-z.

GM-CSF Monocyte-Derived Cells and Langerhans Cells As Part of the Dendritic Cell Family.

Lutz M, Strobl H, Schuler G, Romani N Front Immunol. 2017; 8:1388.

PMID: 29109731 PMC: 5660299. DOI: 10.3389/fimmu.2017.01388.

Induction of CD4(+) Regulatory and Polarized Effector/helper T Cells by Dendritic Cells.

Lutz M Immune Netw. 2016; 16(1):13-25.

PMID: 26937228 PMC: 4770096. DOI: 10.4110/in.2016.16.1.13.

References

Banchereau J, Steinman R . Dendritic cells and the control of immunity. Nature. 1998; 392(6673):245-52. DOI: 10.1038/32588. View

Yamazaki S, Dudziak D, Heidkamp G, Fiorese C, Bonito A, Inaba K . CD8+ CD205+ splenic dendritic cells are specialized to induce Foxp3+ regulatory T cells. J Immunol. 2008; 181(10):6923-33. PMC: 2814590. DOI: 10.4049/jimmunol.181.10.6923. View

McIlroy D, Troadec C, Grassi F, Samri A, Barrou B, Autran B . Investigation of human spleen dendritic cell phenotype and distribution reveals evidence of in vivo activation in a subset of organ donors. Blood. 2001; 97(11):3470-7. DOI: 10.1182/blood.v97.11.3470. View

Valk E, Rudd C, Schneider H . CTLA-4 trafficking and surface expression. Trends Immunol. 2008; 29(6):272-9. PMC: 4186961. DOI: 10.1016/j.it.2008.02.011. View

Sato K, Yamashita N, Yamashita N, Baba M, Matsuyama T . Regulatory dendritic cells protect mice from murine acute graft-versus-host disease and leukemia relapse. Immunity. 2003; 18(3):367-79. DOI: 10.1016/s1074-7613(03)00055-4. View

Adorini L, Penna G . Dendritic cell tolerogenicity: a key mechanism in immunomodulation by vitamin D receptor agonists. Hum Immunol. 2009; 70(5):345-52. DOI: 10.1016/j.humimm.2009.01.016. View

Thomson A, Sacks J, Kuo Y, Ikeguchi R, Horibe E, Unadkat J . Dendritic cell therapy in composite tissue allotransplantation. Transplant Proc. 2009; 41(2):537-8. PMC: 2784640. DOI: 10.1016/j.transproceed.2009.01.011. View

Stax A, Gelderman K, Schlagwein N, Essers M, Kamerling S, Woltman A . Induction of donor-specific T-cell hyporesponsiveness using dexamethasone-treated dendritic cells in two fully mismatched rat kidney transplantation models. Transplantation. 2008; 86(9):1275-82. DOI: 10.1097/TP.0b013e31818a6682. View

Parish I, Rao S, Smyth G, Juelich T, Denyer G, Davey G . The molecular signature of CD8+ T cells undergoing deletional tolerance. Blood. 2009; 113(19):4575-85. PMC: 2680364. DOI: 10.1182/blood-2008-10-185223. View

10.

Lutz M, SURI R, Niimi M, OGILVIE A, Kukutsch N, Rossner S . Immature dendritic cells generated with low doses of GM-CSF in the absence of IL-4 are maturation resistant and prolong allograft survival in vivo. Eur J Immunol. 2000; 30(7):1813-22. DOI: 10.1002/1521-4141(200007)30:7<1813::AID-IMMU1813>3.0.CO;2-8. View

11.

Verdoodt B, Blazek T, Rauch P, Schuler G, Steinkasserer A, Lutz M . The cyclin-dependent kinase inhibitors p27Kip1 and p21Cip1 are not essential in T cell anergy. Eur J Immunol. 2003; 33(11):3154-63. DOI: 10.1002/eji.200323960. View

12.

Dietze B, Cierpka E, Schafer M, Schill W, Lutz M . An improved method to generate equine dendritic cells from peripheral blood mononuclear cells: divergent maturation programs by IL-4 and LPS. Immunobiology. 2008; 213(9-10):751-8. DOI: 10.1016/j.imbio.2008.07.024. View

13.

Powell J, Lerner C, Schwartz R . Inhibition of cell cycle progression by rapamycin induces T cell clonal anergy even in the presence of costimulation. J Immunol. 1999; 162(5):2775-84. View

14.

Schwartz R, Mueller D, Jenkins M, Quill H . T-cell clonal anergy. Cold Spring Harb Symp Quant Biol. 1989; 54 Pt 2:605-10. DOI: 10.1101/sqb.1989.054.01.072. View

15.

Sato K, Yamashita N, Baba M, Matsuyama T . Modified myeloid dendritic cells act as regulatory dendritic cells to induce anergic and regulatory T cells. Blood. 2003; 101(9):3581-9. DOI: 10.1182/blood-2002-09-2712. View

16.

Woltman A, de Fijter J, Kamerling S, Paul L, Daha M, van Kooten C . The effect of calcineurin inhibitors and corticosteroids on the differentiation of human dendritic cells. Eur J Immunol. 2000; 30(7):1807-12. DOI: 10.1002/1521-4141(200007)30:7<1807::AID-IMMU1807>3.0.CO;2-N. View

17.

Peggs K, Quezada S, Allison J . Cell intrinsic mechanisms of T-cell inhibition and application to cancer therapy. Immunol Rev. 2008; 224:141-65. DOI: 10.1111/j.1600-065X.2008.00649.x. View

18.

Wells A, Walsh M, Bluestone J, Turka L . Signaling through CD28 and CTLA-4 controls two distinct forms of T cell anergy. J Clin Invest. 2001; 108(6):895-903. PMC: 200935. DOI: 10.1172/JCI13220. View

19.

Steinman R, Nussenzweig M . Avoiding horror autotoxicus: the importance of dendritic cells in peripheral T cell tolerance. Proc Natl Acad Sci U S A. 2002; 99(1):351-8. PMC: 117564. DOI: 10.1073/pnas.231606698. View

20.

Howland K, Ausubel L, London C, Abbas A . The roles of CD28 and CD40 ligand in T cell activation and tolerance. J Immunol. 2000; 164(9):4465-70. DOI: 10.4049/jimmunol.164.9.4465. View